Biotech Startups
10,002 companies tagged Biotech, with their investors and founders.
ELIAS Animal Health develops ELIAS Cancer Immunotherapy (ECI®), a personalized cancer treatment for dogs that combines an autologous vaccine with adoptive T cell therapy to target a patient's own cancer cells. The USDA-approved treatment for canine bone cancer is delivered through veterinarians and veterinary hospitals at authorized treatment centers across the United States.
0 investors
Eliaz Therapeutics develops XGal-3, an investigational therapeutic apheresis device that uses an antibody-based resin to remove the protein Galectin-3 from the bloodstream. It targets Galectin-3 as a driver of sepsis, cancer, heart disease, fibrosis, and kidney disease, and is in the preclinical and first-in-human study stage.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Emerging Holdings, Inc. develops sustainable cultivation systems for high-value herbal plants and organic oyster mushrooms, combining plant genetics, germplasm development, and biological green technology. The company operates an agricultural property in the Cuyama Valley of Santa Barbara County, California.
0 investors
0 investors
Emmaus Life Sciences is a pharmaceutical company that develops and commercializes Endari (prescription-grade L-glutamine oral powder), an FDA-approved treatment for sickle cell disease, and pursues additional indications such as diverticulosis. The company sells and seeks marketing authorization for its products in the United States and internationally, including the Middle East and North Africa region.
0 investors
0 investors
Emtherapro develops biomarkers and therapies for neurodegenerative diseases, including Alzheimer's disease, using proteomics-based methods. It partners with researchers, biotech and pharmaceutical companies, and healthcare organizations to create new diagnostics and therapies.
0 investors
Enalare Therapeutics is a clinical-stage biopharmaceutical company developing therapies for patients with acute respiratory conditions. It works to advance its drug products through development, regulatory review, and launch.
0 investors
0 investors
San Francisco biotechnology company that filed a $400,000 Regulation D equity offering in April 2023.
0 investors
0 investors
Encore Medical develops cardiovascular medical devices, with clinical work focused on patent foramen ovale (PFO) and related conditions such as migraine. It operates in the cardiovascular medical device sector.
0 investors